Moa Technology Limited
Registered name: MOA TECHNOLOGY LIMITED
Moa Technology Limited made £2.5m revenue and a £9.4m loss in the year to 31 Dec 2025.
Moa Technology Limited’s revenue grew 33% to £2.5m in the year to 31 Dec 2025, with a loss of £9.4m and 83 employees. The company is classified under “research and experimental development on biotechnology” and is based in Oxford; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Oxford, South East
- Age
- 9 yrs · since 2017
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £10k | £1.9m | £2.5m |
| Cost of sales | £0 | £22k | £69.4k |
| Gross profit | £10k | £1.9m | £2.4m |
| Operating profit | −£15.9m | −£13.4m | −£11.4m |
| Profit before tax | −£14.9m | −£12.7m | −£11.2m |
| Profit after tax | −£12.3m | −£10.8m | −£9.4m |
| Profit (best available) | −£12.3m | −£10.8m | −£9.4m |
| Staff costs | £5.4m | £5.8m | £6.2m |
| Employees (average) | 62 | 81 | 83 |
| Ratios | |||
| Profit margin | −122890% | −566.8% | −374.1% |
| Gross margin | 100% | 98.8% | 97.2% |
| Revenue per employee | £161 | £23.5k | £30.3k |
| Profit per employee | −£198k | −£133k | −£114k |
| Growth (year on year) | |||
| Revenue growth | — | — | ▲32.6% |
| Headcount growth | — | — | ▲2.5% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £18.9m | £11.4m | £5.7m |
| Net assets | £22.2m | £12.2m | £3.2m |
| Fixed assets | £1.3m | £1.2m | £732k |
| Current assets | £22.1m | £13.8m | £7.9m |
| Debtors | £3.1m | £2.4m | £2.2m |
| Deferred income | £266k | £729k | £1.2m |
| Cash from operations | −£13.2m | −£7.9m | −£6.9m |
| Source | FullAccounts · bulk data Apr 2025 | FullAccounts · bulk data Apr 2025 | FullAccounts · bulk data May 2026 |
How the business works
- Profit margin
- −374.1%
- Profit ÷ revenue.
- Gross margin
- 97.2%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £30.3k
- Revenue ÷ average employees.
- Profit per employee
- −£114k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 29.1%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 49.4%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 85.6%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼74%
- Now £3.2m
- Cash at bank
- ▼50%
- Now £5.7m
- Headcount
- ▲2%
- Now 83
- Deferred income
- ▲71%
- Now £1.2m
- Fixed assets
- ▼38%
- Now £732k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Minority corporate shareholders
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Clinicology Ltd.Guildford · Research and experimental development on biotechnology
- Revenue
- £1.4m
- Profit
- £79.1k
- Staff
- 7
- Adorx Therapeutics LimitedEdinburgh · Research and experimental development on biotechnology
- Revenue
- £1.2m
- Profit
- £211k
- Staff
- 0
- Nuritas UK LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £1.2m
- Profit
- £88.8k
- Staff
- 4
- Clinuvel (UK) LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £6.4m
- Profit
- £81.6k
- Staff
- 46
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£9.4m), from the Companies House accounts bulk data published May 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.